Cargando…
αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum
BACKGROUND: Rare pathogenic variants in either the ITGA2B or ITGB3 genes have been linked to autosomal dominant macrothrombocytopenia associated with abnormal platelet production and function, deserving the designation of Glanzmann Thrombasthenia-Like Syndrome (GTLS) or ITGA2B/ITGB3-related thromboc...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717987/ https://www.ncbi.nlm.nih.gov/pubmed/33276370 http://dx.doi.org/10.1371/journal.pone.0235136 |
_version_ | 1783619416440700928 |
---|---|
author | Morais, Sara Oliveira, Jorge Lau, Catarina Pereira, Mónica Gonçalves, Marta Monteiro, Catarina Gonçalves, Ana Rita Matos, Rui Sampaio, Marco Cruz, Eugénia Freitas, Inês Santos, Rosário Lima, Margarida |
author_facet | Morais, Sara Oliveira, Jorge Lau, Catarina Pereira, Mónica Gonçalves, Marta Monteiro, Catarina Gonçalves, Ana Rita Matos, Rui Sampaio, Marco Cruz, Eugénia Freitas, Inês Santos, Rosário Lima, Margarida |
author_sort | Morais, Sara |
collection | PubMed |
description | BACKGROUND: Rare pathogenic variants in either the ITGA2B or ITGB3 genes have been linked to autosomal dominant macrothrombocytopenia associated with abnormal platelet production and function, deserving the designation of Glanzmann Thrombasthenia-Like Syndrome (GTLS) or ITGA2B/ITGB3-related thrombocytopenia. OBJECTIVES: To describe a series of patients with familial macrothrombocytopenia and decreased expression of αIIbβ3 integrin due to defects in the ITGA2B or ITGB3 genes. METHODS: We reviewed the clinical and laboratory records of 10 Portuguese families with GTLS (33 patients and 11 unaffected relatives), including the functional and genetic defects. RESULTS: Patients had absent to moderate bleeding, macrothrombocytopenia, low αIIbβ3 expression, impaired platelet aggregation/ATP release to physiological agonists and low expression of activation-induced binding sites on αIIbβ3 (PAC-1) and receptor-induced binding sites on its ligand (bound fibrinogen), upon stimulation with TRAP-6 and ADP. Evidence for constitutive αIIbβ3 activation, occurred in 2 out of 9 patients from 8 families studied, but also in 2 out of 12 healthy controls. We identified 7 missense variants: 3 in ITGA2B (5 families), and 4 in ITGB3 (5 families). Three variants (αIIb: p.Arg1026Trp and p.Arg1026Gln and β3: p.Asp749His) were previously reported. The remaining (αIIb: p.Gly1007Val and β3: p.Thr746Pro, p.His748Pro and p.Arg760Cys) are new, expanding the αIIbβ3 defects associated with GTLS. The integration of the clinical and laboratory data allowed the identification of two GTLS subgroups, with distinct disease severity. CONCLUSIONS: Previously reported ITGA2B and ITGB3 variants related to thrombocytopenia were clustered in a confined region of the membrane-proximal cytoplasmic domains, the inner membrane clasp. For the first time, variants are reported at the outer membrane clasp, at the transmembrane domain of αIIb, and at the membrane distal cytoplasmic domains of β3. This is the largest single-center series of inherited macrothrombocytopenia associated with αIIbβ3 variants published to date. |
format | Online Article Text |
id | pubmed-7717987 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-77179872020-12-11 αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum Morais, Sara Oliveira, Jorge Lau, Catarina Pereira, Mónica Gonçalves, Marta Monteiro, Catarina Gonçalves, Ana Rita Matos, Rui Sampaio, Marco Cruz, Eugénia Freitas, Inês Santos, Rosário Lima, Margarida PLoS One Research Article BACKGROUND: Rare pathogenic variants in either the ITGA2B or ITGB3 genes have been linked to autosomal dominant macrothrombocytopenia associated with abnormal platelet production and function, deserving the designation of Glanzmann Thrombasthenia-Like Syndrome (GTLS) or ITGA2B/ITGB3-related thrombocytopenia. OBJECTIVES: To describe a series of patients with familial macrothrombocytopenia and decreased expression of αIIbβ3 integrin due to defects in the ITGA2B or ITGB3 genes. METHODS: We reviewed the clinical and laboratory records of 10 Portuguese families with GTLS (33 patients and 11 unaffected relatives), including the functional and genetic defects. RESULTS: Patients had absent to moderate bleeding, macrothrombocytopenia, low αIIbβ3 expression, impaired platelet aggregation/ATP release to physiological agonists and low expression of activation-induced binding sites on αIIbβ3 (PAC-1) and receptor-induced binding sites on its ligand (bound fibrinogen), upon stimulation with TRAP-6 and ADP. Evidence for constitutive αIIbβ3 activation, occurred in 2 out of 9 patients from 8 families studied, but also in 2 out of 12 healthy controls. We identified 7 missense variants: 3 in ITGA2B (5 families), and 4 in ITGB3 (5 families). Three variants (αIIb: p.Arg1026Trp and p.Arg1026Gln and β3: p.Asp749His) were previously reported. The remaining (αIIb: p.Gly1007Val and β3: p.Thr746Pro, p.His748Pro and p.Arg760Cys) are new, expanding the αIIbβ3 defects associated with GTLS. The integration of the clinical and laboratory data allowed the identification of two GTLS subgroups, with distinct disease severity. CONCLUSIONS: Previously reported ITGA2B and ITGB3 variants related to thrombocytopenia were clustered in a confined region of the membrane-proximal cytoplasmic domains, the inner membrane clasp. For the first time, variants are reported at the outer membrane clasp, at the transmembrane domain of αIIb, and at the membrane distal cytoplasmic domains of β3. This is the largest single-center series of inherited macrothrombocytopenia associated with αIIbβ3 variants published to date. Public Library of Science 2020-12-04 /pmc/articles/PMC7717987/ /pubmed/33276370 http://dx.doi.org/10.1371/journal.pone.0235136 Text en © 2020 Morais et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Morais, Sara Oliveira, Jorge Lau, Catarina Pereira, Mónica Gonçalves, Marta Monteiro, Catarina Gonçalves, Ana Rita Matos, Rui Sampaio, Marco Cruz, Eugénia Freitas, Inês Santos, Rosário Lima, Margarida αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum |
title | αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum |
title_full | αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum |
title_fullStr | αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum |
title_full_unstemmed | αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum |
title_short | αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum |
title_sort | αiibβ3 variants in ten families with autosomal dominant macrothrombocytopenia: expanding the mutational and clinical spectrum |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717987/ https://www.ncbi.nlm.nih.gov/pubmed/33276370 http://dx.doi.org/10.1371/journal.pone.0235136 |
work_keys_str_mv | AT moraissara aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT oliveirajorge aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT laucatarina aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT pereiramonica aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT goncalvesmarta aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT monteirocatarina aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT goncalvesanarita aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT matosrui aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT sampaiomarco aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT cruzeugenia aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT freitasines aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT santosrosario aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum AT limamargarida aiibb3variantsintenfamilieswithautosomaldominantmacrothrombocytopeniaexpandingthemutationalandclinicalspectrum |